skip to Main Content

Our research is driven by the aim of developing “one shot” eye therapies suitable for curing blinding or fatal eye diseases in low resource settings. With this in mind, we concentrate on developing

  1. Intraocular gene therapy for macular degeneration which can be given in a once off injection
  2. Diabetic retinopathy diagnosis and treatments with existing medications and lasers
  3. Cancer gene therapy for treatment of eye melanoma

Publication in “Gene Therapy” for LVF Scholar

Slawomir Andrzejewski had great success in April with international publication of his first manuscript in the prestigious journal “Gene Therapy”,…

LVF Scholars Scoop Awards at International Conference

Two Layton Vision Foundation Scholars awarded for their work at the EVER conference in Nice, France. After an astounding seven…

International Research Award for LVF Scholar

The European Association for Research in Vision and Ophthalmology has awarded Gabriela de Moraes, a scholar working in the Ophthalmology…

Researcher profile: Dr Sean Jenkins

Sean is a postdoctorate clinical researcher in the Ophthalmology Research Unit working under A/Professor Layton’s supervision. He trained in scientific…

Back To Top